Latest Articles
Projecting the Global Endometrial Ablation Devices Market Size to Expand at a 5.21% CAGR Through 2032, DelveInsight Analysis - Barchart
Projecting the Global Endometrial Ablation Devices Market Size to Expand at a 5.21% CAGR Through 2032, DelveInsight Analysis Barchart
Published: March 27, 2026, 1:44 p.m.
CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition | Xing | Folia Histochemica et Cytobiologica - Via Medica Journals
CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition | Xing | Folia Histochemica et Cytobiologica Via Medica Journals
Published: March 27, 2026, 12:27 p.m.
CSHL develops endometrial cancer organoid platform - Cold Spring Harbor Laboratory
CSHL develops endometrial cancer organoid platform Cold Spring Harbor Laboratory
Published: March 26, 2026, 6:59 p.m.
Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism - Nature
Polystyrene nanoparticles promote endometrial cancer development through the ACSS2-mediated reprogramming of arachidonic acid metabolism Nature
Published: March 26, 2026, 6:57 a.m.
Extra-uterine Endometrial Stromal Sarcoma of the Stomach Mimicking a Gastrointestinal Stromal Tumour: A Case Report - Cureus
Extra-uterine Endometrial Stromal Sarcoma of the Stomach Mimicking a Gastrointestinal Stromal Tumour: A Case Report Cureus
Published: March 23, 2026, 7:25 p.m.
Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials - AboutLawsuits.com
Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials AboutLawsuits.com
Published: March 23, 2026, 4 p.m.
New Process Could Identify High Risk of Developing Endometrial Cancer - Worldwide Cancer Research
New Process Could Identify High Risk of Developing Endometrial Cancer Worldwide Cancer Research
Published: March 23, 2026, 10:38 a.m.
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma - Oncology Central
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma Oncology Central
Published: March 23, 2026, 9:45 a.m.
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma - Oncology Central
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma Oncology Central
Published: March 23, 2026, 9:45 a.m.
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence - Nature
Design and evaluation of a custom circulating tumour DNA assay to detect endometrial cancer recurrence Nature
Published: March 23, 2026, 8:51 a.m.
Link copied to clipboard!